Wednesday, July 8, 2026

pharma · Opioid Use Disorder · Opioid Dependence

Indivior Pty

Indivior is a pharma organization headquartered in Richmond, USA. Primary therapeutic focus areas include Opioid Use Disorder, Opioid Dependence, Schizophrenia, Opioid Dependency, Opiate Dependence. NovaPharmaNews links

., Richmond, VA, US HQ
967 Employees
TGA registrant Type
Company details
Status
Public
HQ
., Richmond, VA, US
Employees
967
Programs
39
Drugs
19
Patents
34
Clinical program

Arbaclofen Placarbil SR

Phase 1 · small molecule · Healthy Volunteers

Arbaclofen Placarbil SR for Healthy Volunteers is a Phase 1 program (small_molecule) at Indivior Pty Ltd with 1 ClinicalTrials.gov record(s).

← All Indivior Pty Ltd projects Phase 1 small molecule completed

Internal code INDV-AP-102

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Indivior Pty Ltd
Phase
Phase 1
Modality
small_molecule
Indication
Healthy Volunteers
Status
completed
Trials
1